Eg5 inhibitor YL001 induces mitotic arrest and inhibits tumor proliferation
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.17207
Abstract: Eg5 is a kinesin spindle protein that controls chromosomal segregation in mitosis and is thus a critical drug target for cancer therapy. We report the discovery of a potent, selective inhibitor of Eg5 designated YL001.… read more here.
Keywords: cancer; inhibits tumor; yl001; eg5 inhibitor ... See more keywords